Ameriprise Financial Inc. bought a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 42,418 shares of the company's stock, valued at approximately $340,000. Ameriprise Financial Inc. owned 0.11% of Viemed Healthcare as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its position in Viemed Healthcare by 18.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,005 shares of the company's stock valued at $105,000 after purchasing an additional 1,997 shares during the period. LPL Financial LLC raised its position in Viemed Healthcare by 1.6% in the fourth quarter. LPL Financial LLC now owns 194,690 shares of the company's stock valued at $1,561,000 after purchasing an additional 3,000 shares during the period. Martingale Asset Management L P raised its position in Viemed Healthcare by 11.0% in the fourth quarter. Martingale Asset Management L P now owns 34,836 shares of the company's stock valued at $279,000 after purchasing an additional 3,451 shares during the period. Bard Associates Inc. raised its position in Viemed Healthcare by 1.3% in the fourth quarter. Bard Associates Inc. now owns 349,526 shares of the company's stock valued at $2,803,000 after purchasing an additional 4,474 shares during the period. Finally, Northern Trust Corp raised its position in Viemed Healthcare by 1.8% in the fourth quarter. Northern Trust Corp now owns 286,818 shares of the company's stock valued at $2,300,000 after purchasing an additional 5,090 shares during the period. Hedge funds and other institutional investors own 74.24% of the company's stock.
Viemed Healthcare Stock Performance
NASDAQ:VMD opened at $6.59 on Friday. Viemed Healthcare, Inc. has a 52 week low of $6.14 and a 52 week high of $9.81. The company has a fifty day simple moving average of $6.77 and a two-hundred day simple moving average of $7.62. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03. The company has a market cap of $260.46 million, a price-to-earnings ratio of 24.41 and a beta of 1.38.
Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 earnings per share for the quarter, hitting analysts' consensus estimates of $0.06. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The business had revenue of $59.10 million for the quarter, compared to analyst estimates of $60.60 million.
Viemed Healthcare Profile
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Further Reading
Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.